Clinical Trial Update: Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating Zevalin before stem cell transplant in patients with refractory or relapsed non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: Joseph Tuscano | Conditions: Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN